Long-term healthcare utilisation, costs and quality of life after invasive group B Streptococcus disease: a cohort study in five low-income and middle-income countries.
Farah SeedatSimon R ProcterZiyaad DangorShannon LeahySridhar SanthanamHima B JohnSozinho AcácioCeline AertsAmina AbubakarCarophine NasambuRomina LibsterClara Sánchez YanottiProma PaulJaya ChandaBronner P GonçalvesErzsébet Horváth-PuhóJoy E Lawnnull nullMark JitPublished in: BMJ global health (2024)
The iGBS health and economic burden may persist for years after acute disease. Larger studies are needed for more robust estimates to inform the cost-effectiveness of iGBS prevention.